NCT04446039 - Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea | Biotech Hunter

Enrollment

370,212

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

November 3, 2022

Study Completion Date

November 3, 2022

Conditions

Major Depression

Interventions

DRUG

Escitalopram

Treatment for depression

DRUG

Paroxetine

Treatment for depression

DRUG

Fluoxetine

Treatment for depression

DRUG

Mirtazapine

Treatment for depression

DRUG

Duloxetine

Treatment for depression

DRUG

Sertraline

Treatment for depression

DRUG

Venlafaxine

Treatment for depression

DRUG

Tianeptine

Treatment for depression

DRUG

Vortioxetine

Treatment for depression

DRUG

Desvenlafaxine

Treatment for depression

DRUG

Bupropion

Treatment for depression

Trial Locations (1)

Unknown

Pfizer, Seoul